Kopran Ltd. (KOPRAN) Share Price rises 13.09% as stock gains today
- August 31, 2026
- Posted by: Harsh Piplani
- Category: News
Kopran Ltd. Share Price moved higher today, with the stock at Rs 227.60 after a 13.09% rise from the previous close of Rs 201.25. The company’s market capitalisation stands at Rs 971.75 crore, placing the move in a clearly measurable market context for Kopran Ltd. Share Price Today tracking. The session opened at Rs 202.05, touched a high of Rs 234.80 and a low of Rs 202.05, while turnover stood at Rs 1.52 crore.
This Kopran Ltd. Stock News item confirms the price event, but the supplied data does not establish a company-specific catalyst. For readers following Kopran Ltd. Share News, the key question is not only why the stock is rising today, but what the verified numbers say about valuation, industry context and how the move compares with the wider healthcare pack. Univest is tracking the same set of facts so investors can read the move alongside market cap, fundamentals and sector benchmarks.
Kopran Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 227.6 |
| Previous Close | Rs 201.25 |
| Today's Move | Rs 26.35 (+13.09%) |
| Open | Rs 202.05 |
| High | Rs 234.8 |
| Low | Rs 202.05 |
| Turnover | Rs 1.52 crore |
| Market Capitalisation | Rs 971.75 crore |
| Market Cap Category | Micro Cap |
Kopran Ltd. (KOPRAN) rose to Rs 227.6 from the previous close of Rs 201.25, a move of Rs 26.35 or 13.09%. The stock opened at Rs 202.05, reached a high of Rs 234.8, recorded a low of Rs 202.05.
Kopran Ltd. opened at Rs 202.05 and stayed above that level through the session, with the day’s low also at Rs 202.05 and the day’s high at Rs 234.80. The stock closed at Rs 227.60, up Rs 26.35 or 13.09% from the previous close of Rs 201.25. Turnover for the session was Rs 1.52 crore. This is the factual price action behind today’s Kopran Ltd. Share Price move and the latest Kopran Ltd. Share Price Update on NSE and BSE tracking pages.
For investors scanning Kopran Ltd. Share Price Live and Kopran Ltd. Stock Gaining Today, the move is meaningful because it is both sharp and clearly measurable. Still, the supplied data only confirms the rise; it does not confirm what caused it. In Stock Market Today terms, Kopran Ltd. is among the names appearing in Stocks in News and Stocks Rising Today on a purely price-based basis.
Kopran Ltd. (KOPRAN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 971.75 crore |
| P/E Ratio | 38.89x |
| P/B Ratio | 1.81x |
| ROE | 4.92% |
| ROCE | 6.65% |
| EPS | Rs 5.17 |
| Book Value Per Share | Rs 110.92 |
| Dividend Yield | 1.49% |
Kopran Ltd. (KOPRAN) fundamental metrics show P/E 38.89x, P/B 1.81x, ROE 4.92%, ROCE 6.65%. These figures provide context only and are not a buy or sell signal.
Kopran Ltd. has a market capitalisation of Rs 971.75 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.89x, P/B at 1.81x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.92% and ROCE of 6.65%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 5.17, book value per share of Rs 110.92, dividend yield of 1.49%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.21x, median ROE of 11.78%, median ROCE of 13.6%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.89x |
| Benchmark Median P/E | 31.21x |
| Benchmark Average P/E | 48.1x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 1.81x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 4.92% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 6.65% |
| Benchmark Median ROCE | 13.6% |
| Company Market Capitalisation | Rs 971.75 crore |
| Benchmark Median Market Cap | Rs 670.73 crore |
Kopran Ltd. (KOPRAN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Kopran Ltd. (KOPRAN) has a P/E ratio of 38.89x, which is above the benchmark median of 31.21x, a difference of +24.61%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Kopran Ltd. (KOPRAN) has a ROE of 4.92%, which is below the benchmark median of 11.78%, a difference of -58.23%. Kopran Ltd. (KOPRAN) has a ROCE of 6.65%, which is below the benchmark median of 13.6%, a difference of -51.1%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,60,696.31 | 38.09 | 5.33 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,062.83 | 84.12 | 13.93 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,91,515.22 | 87.81 | 21.34 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,403.7 | 26.24 | 4.39 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.99 | 3.26 | 11.83 | 16 |
Kopran Ltd. (KOPRAN) has a P/E ratio of 38.89x compared with the displayed peer median of 38.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.92% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.65% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Kopran Ltd. (KOPRAN) has a market capitalisation of Rs 971.75 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Kopran Ltd.
- The Kopran Ltd. Share Price closed at Rs 227.60, up 13.09% from Rs 201.25 in the previous session.
- Intraday trade showed a low of Rs 202.05 and a high of Rs 234.80, with turnover at Rs 1.52 crore.
- Market capitalisation stands at Rs 971.75 crore, giving clear Kopran Ltd. Stock Performance context.
- P/E is 38.89, P/B is 1.81, ROE is 4.92% and ROCE is 6.65%.
- In the Healthcare sector, the company’s valuation and return ratios sit below several benchmark medians.
About Kopran Ltd.
Kopran Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied company context, it is part of a large and diverse pharmaceutical ecosystem that includes branded, generic and specialty businesses across India’s listed healthcare universe. For readers searching Kopran Ltd. Company News or Kopran Ltd. Latest News, the important point is that the firm is being analysed today primarily through its price move, valuation and peer positioning.
The company’s current market capitalisation of Rs 971.75 crore, P/E of 38.89, P/B of 1.81, ROE of 4.92% and ROCE of 6.65% frame how the market may compare it with larger pharmaceutical names. EPS of Rs 5.17, book value of Rs 110.92 and dividend yield of 1.49% further define the stock’s financial profile. Univest uses these facts to keep the narrative focused on verified company data rather than speculation.
Track Kopran Ltd. Share Price on Univest
Use Kopran Ltd. (KOPRAN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Kopran Ltd. Share Price today?
Ans. Kopran Ltd. Share Price Today is Rs 227.60, compared with the previous close of Rs 201.25. The stock added Rs 26.35 in the session and was active in the healthcare space.
What does the market capitalisation of Kopran Ltd. show?
Ans. Kopran Ltd. has a market capitalisation of Rs 971.75 crore. Market cap indicates company size, not quality, and it helps place the stock within the Healthcare and Pharmaceuticals & Drugs universe.
How does Kopran Ltd. compare with industry valuation benchmarks?
Ans. Kopran Ltd. trades at a P/E of 38.89 and P/B of 1.81. Its P/E is above the industry median of 31.21, while its P/B is below the industry median of 2.88.
What do Kopran Ltd. profitability ratios indicate?
Ans. Kopran Ltd. reports ROE of 4.92% and ROCE of 6.65%. Both are below the same-industry medians, which gives investors a clear profitability context for the current Kopran Ltd. Share Price.
What are the key financial metrics for Kopran Ltd.?
Ans. The supplied financial metrics include EPS of Rs 5.17, book value of Rs 110.92 and dividend yield of 1.49%. Together with P/E and P/B, they help frame Kopran Ltd. Fundamental Analysis.
How did Kopran Ltd. trade during the session?
Ans. The stock opened at Rs 202.05, matched its day low at Rs 202.05 and reached a high of Rs 234.80. It closed at Rs 227.60, with turnover of Rs 1.52 crore.
Which peers are useful for Kopran Ltd. Share Price comparison?
Ans. Useful peer references include Sun Pharmaceutical Industries Ltd., Divi’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd. and Cipla Ltd. They provide a useful valuation and profitability comparison set. The previous close was Rs 201.25.
